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Using mutational analysis, we have investigated the translation strategy of the reverse transcriptase gene
(pol) of human hepatitis B virus. It has been proposed that this pol gene product is synthesized as a core-pol
fusion protein from a polycistronic mRNA template via ribosomal frameshifting, a mechanism often seen in
retroelements. Our data indicate that creation of a novel ATG initiation codon near the original ATG can
compensate for a lethal missense mutation at the first ATG position of the pol open reading frame. Genetic
analysis has rigorously ruled out the possibilities of frameshifting, non-ATG initiation, or RNA editing. These
results are discussed in the context of a 5'-end entry model versus a novel model of direct internal entry of
ribosomes.
Reverse transcriptase (pot) was independently discovered
in retroviruses almost 2 decades ago by Baltimore (1) and
Temin and Mizutani (39). It was demonstrated by Summers
and Mason that DNA animal viruses such as duck hepatitis
B virus (duck HBV) could also replicate via reverse tran-
scription (38). The ubiquity of reverse transcriptase has also
been supported by the recent discovery of this enzyme in
procaryotes (11, 21). In many cases, the pol open reading
frame (ORF) is overlapped by and out of frame to a 5'
upstream nucleocapsid ORF within the same polycistronic
mRNA (e.g., for HBV, see Fig. 1). The biosynthesis of this
enzyme in retroviruses involves the formation of a gag-pol
fusion protein by either ribosomal frameshifting (fs) (12) or
readthrough of an amber stop codon between the nucleocap-
sid (gag) and pol genes (44). For human HBV, it has been
proposed that the synthesis of the pol gene product from a
3.5-kilobase (kb) polycistronic mRNA (Fig. 1) also involves
the formation of a nucleocapsid-pol (designated c-pot) fusion
protein via fs (43).
Identification and characterization of the pol gene product
with anti-pol antibodies in hepatocytes by active HBV
replication (2, 22) have proven difficult because of either
poor immunogenicity or small amounts of the pol protein.
One hypothesis concerning HBV pol gene expression via
ribosomal fs has been examined by genetic analysis in the
duck HBV system (4, 33). Using a trans-rescue genetic
approach, a pol-defective mutant has been successfully
complemented by cotransfection with a core-defective non-
sense mutant, indicating that core and pol gene products can
be synthesized separately (4, 33). Here, we report a comple-
mentary cis-rescue approach to investigate pol gene expres-
sion in the human HBV system. Our results provide further
convincing evidence against the requirement of the forma-
tion of a core-pol fusion protein in HBV via ribosomal fs.
MATERIALS AND METHODS
Site-directed mutagenesis. The procedure for site-directed
mutagenesis was adapted from that of Kunkel (18). Plasmid
RG6 contains a full-length HBV monomer DNA in the minus
orientation in the EcoRI site of vector M13mpl8. A uracil-
containing single-stranded DNA template of RG6 was pre-
pared by infecting RG6 bacteriophage in a growing culture of
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CJ236 in the presence of uridine (0.25 ,ug/ml) and chloram-
phenicol (30 ,ug/ml). The oligonucleotides used for construc-
tion of the HBV mutants are shown below.
Nucleotide no. of Olignucleotide sequence
mutant position
5' *
2306 GAC CAC TAA ATG CCC CTATC
2310 GAC CAC CAA ACG CCC CTATC
*
2471 TGG ACT CAT TAG GTG GGGAA
305 CGT GTG TCT TAG CCA AAATT
*
1314 AGC AGG TCT TGA GCA AACAT
2299 CTC CAG CTT ATG GAC CACCA
2342 CGG AGA CTA ATG TTG TTAGA
Approximately 100 to 200 ng of oligonucleotide was phos-
phorylated with T4 polynucleotide kinase and then annealed
to 1 ,ug of uracil-containing, single-stranded RG6 template
DNA. The resulting hybrid DNA was extended with T4
DNA polymerase and ligated with T4 DNA ligase. A sample
of the ligation mixture (about 100 ng of DNA) was trans-
formed into MV1304 Escherichia coli cells and then plated in
the presence of MV1304. Mutant HBV clones were screened
for the mutant sequence by the Sanger dideoxy technique
(32) (Sequenase obtained from U.S. Biochemical Co.).
Construction of MC-3 vector. A pSV2ANeo-HBV mono-
mer vector was constructed as described previously (14, 35).
This vector contains two EcoRI sites flanking the full-length
3.2-kb HBV DNA fragments (ayw subtype of HBV). The
transcription of HBV pre-core promoter in this vector is in
the same direction as that for the neomycin resistance gene.
In order to dimerize the HBV genome efficiently, the down-
stream EcoRI site of the pSV2ANeo-HBV monomer was
eliminated, resulting in a pSV2ANeo-HBV monomer with a
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FIG. 1. Transcription map of HBV drawn with a DNA template in a head-to-tail tandem dimer configuration, which is like a circular
permutation of a covalently closed circular form. The four different ORFs are shown by solid bars. The 2.5-kb mRNA encodes the pre-surface
antigen (pre-Sl), and the 2.1-kb mRNA encodes another pre-surface antigen (pre-S2) and surface antigen (S). The polymerase gene (po) is
in the +1 frame with respect to the overlapping nucleocapsid gene (C), and the X ORF encodes a putative transactivator (for a review, see
references 7, 23, and 41).
single upstream EcoRI site. This vector was designated
MC-3. Briefly, the pSV2ANeo-HBV monomer (35) was
linearized by EcoRI partial digestion. The 9.5-kb DNA
fragment of this linearized pSV2ANeo-HBV monomer was
electroeluted from a 1.2% agarose gel. The EcoRI end of this
eluted fragment was eliminated by Klenow repair. After
blunt-end religation, the ligated DNA mixture was trans-
formed into E. coli. Loss of the downstream or upstream
EcoRI site was differentiated by cleavage with an AccI or
AccI-plus-EcoRI double digest.
Dimerization of HBV DNA. The construction of a wild-
type HBV dimer expression vector has been described
elsewhere (35). For the dimerization of mutant HBV DNAs,
the aforementioned MC-3 plasmid was used. The 3.1-kb
mutant HBV DNA fragment was isolated from the phage
DNA of the M13mpl8-HBV mutant by complete digestion
with EcoRI and was electroeluted from agarose gel. This
purified mutant HBV DNA fragment was ligated to the MC-3
vector which had been linearized by EcoRI and dephospho-
rylated by alkaline phosphatase. A sample of the ligation
mixture was transformed into E. coli MV1304. Head-to-tail
tandem dimers were screened by XhoI or AccI digestion of
miniprep DNA. For the construction of double mutants, the
uracil template of mutant 2310 was used. Double mutants
were also confirmed by the Sanger dideoxy sequencing
method (32).
Cell culture and transfection. The human hepatoma cell
line HepG2 was maintained in 10% fetal bovine serum in
Dulbecco modified Eagle medium at 37°C in the presence of
5.5% CO2. The calcium phosphate transfection procedure
was followed as detailed elsewhere (35). Briefly, 7 x 105
cells per 10-cm dish were transfected with 5 ,ug of either
wild-type dimer or mutant dimer DNA plus 30 ,ug of human
genomic DNA as carrier. A control dish transfected with
HBV monomer DNA was always included. Donor DNA was
removed 4 h after transfection, and cells were fed with fresh
Dulbecco modified Eagle medium containing 10% fetal bo-
vine serum.
Analysis of HBV expression. Five days after transfection,
medium was removed and saved for further analysis (see
below). Cells from one 10-cm dish (6 x 106 cells) were lysed
to prepare intracellular, extrachromosomal HBV DNA by
the Hirt method (10). Total cellular RNA was prepared from
cells from another 10-cm dish by the method of Chirgwin et
al. (5) (see Fig. 3b), and cells from a third 10-cm dish were
used to prepare intracellular core particles for an endoge-
nous-polymerase assay (15, 38; see below).
Core particle-associated endogenous-polymerase activity.
The procedure for preparation of intracellular core particles
was adapted from the method of Summers and Mason (38).
Briefly, cells from a 10-cm dish (6 x 106 cells) were lysed in
0.5 ml of chilled extraction buffer (20 mM Tris hydrochloride
[pH 7.4], 7 mM MgSO4, 50 mM NaCl, 0.1% P-mercaptoeth-
anol, 100 ,ug of bovine serum albumin per ml, 0.25 M
sucrose) with a Dounce homogenizer. The homogenates
were then spun in a Microfuge (Beckman Instruments, Inc.)
at 4°C for 30 min to remove cellular debris and nuclei. The
clear homogenates were loaded on a sucrose gradient (5 ml
of 15 to 30% sucrose [wt/vol] in extraction buffer). The
gradients were run at 32,000 rpm for 6 h at 4°C in a Beckman
SW50.1 rotor. Fractions (200 RIu) were collected from the
bottom of the gradient, and core particle fractions were
pooled. The particles from pooled fractions were pelleted by
spinning them at 35,000 rpm for 14 h at 4°C in a Beckman
SW50.1 rotor. The pellets were suspended in 100 ,ul of
extraction buffer, and 40-pd samples were used for the
polymerase assay as described elsewhere (35).
Preparation of extracellular HBV DNA. Extracellular DNA
was prepared from 72-h-conditioned medium from three
10-cm dishes (total, 30 ml) collected 5 days after transfec-
tion. The medium was precleared by spinning it at 35,000 x
g for 30 min at 4°C. Particles from the precleared medium
were pelleted by spinning them at 25,000 rpm in a Beckman
SW28 rotor for 16 h at 4°C. The pellets were suspended in 0.5
ml of 10 mM Tris hydrochloride-10 mM EDTA-0.6% so-
dium dodecyl sulfate buffer (pH 7.5) and digested with 400
,ug of proteinase K per ml for 3 h at 37°C. After phenol and
chloroform extractions, the DNAs were precipitated and
redissolved in 30 ,ul ofTE (10 mM Tris hydrochloride, 1 mM
EDTA buffer [pH 7.5]) and analyzed on a 1% agarose gel by
the Southern procedure (37).
RESULTS
Mutant 2310. A point mutation was introduced into the
first ATG codon of the HBV pol ORF at nucleotide (nt) 2310,
converting methionine to threonine while keeping the core
protein unaltered (Fig. 2A). Upon tandem dimerization and
transfection of this mutant into the human hepatoma HepG2
cell line, the functional activities of mutant 2310 were
assayed in parallel with those of the wild-type HBV dimer
control as described in the legend of Fig. 2. Neither HBV-
specific DNA replicative intermediates, as measured by
Southern blot analysis, nor polymerase activity could be
detected.
These results with this mutant suggest that ribosomal fs is
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FIG. 2. (A) Schematic representation of different mutation positions in the pol ORF. The nucleotide number (HBV subtype ayw) indicates
the position of the base change. None of the mutations except that at nt 2306 change the coding capacity of any overlapping ORF. For the
sake of clarity, this figure is not drawn to scale. Symbols: 0, ATG; *, stop codon. S, X, and pol are explained in the legend to Fig. 1. (B)
Southern blot analysis of wild-type and mutant HBV DNA replicative intermediates. Both relaxed-circle and minus-strand, single-stranded
forms are characteristic replicative-intermediate molecular forms of HBV that occur during reverse transcription (7, 23, 41). All the bands
above the 6.0-kb position represent the residual donor DNA of the HBV dimer in the pSV2A vector. These "contaminating" bands serve as
convenient internal references to assess transfection efficiency and the relative amount of donor DNA applied to each recipient culture. (C)
Core particle-associated endogenous polymerase activity of wild-type and mutant HBV. Base substitution mutants 1314 and 2471, which
contain a truncated pol gene, are included as negative controls. With a longer chase, more full-length open circles can be seen at positions
near 4.3 kb. RC, Relaxed circle; SS, single stranded; WT, wild-type HBV. Lanes MC, MC-3 vector (see Materials and Methods).
not likely to occur downstream from the ATG codon. If fs
does occur downstream from this position, the change from
methionine to threonine at position 2310 would not change
the amino acid sequence of the c-pol fusion protein; there-
fore, mutant 2310 should not be lethal. The fact that mutant
2310 exhibits no detectable pol activity (Fig. 2B and C)
suggests that fs cannot occur downstream from position
2310.
Mutant 2306. A ribosomal fs occurring upstream from the
first ATG of pol in wild-type HBV will generate a core-pol
fusion protein with an internal methionine residue at nt 2310.
A missense mutation at this position might abolish the
enzymatic activity ofpol completely. To rule this out, a stop
codon was introduced at position 2306, which is in frame
with and immediately adjacent to the first ATG codon of pol
(Fig. 2A). If fs occurs upstream from position 2306, the
frameshifted ribosome should be arrested when it encoun-
ters the created stop codon at nt 2306. Functional analysis of
this nonsense mutant 2306 indicated that both DNA replica-
tive intermediates and polymerase activity are clearly de-
tectable (Fig. 2). Although the level of activity appeared to
be significantly lower than that of the wild type, it is clearly
significantly above the background level. This difference
between wild-type and mutant 2306 cannot be attributed to a
concurrent structural alteration of the core protein by muta-
tion 2306, which converts a proline residue into a leucine,
since cotransfection of mutant 2306 with other pol mutants
producing wild-type core protein failed to restore the poly-
merase activity to the wild-type level (see Discussion).
Examination of the steady-state mRNA levels by Northern
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FIG. 3. (A) Schematic representation of the positions of newly created methionine codons in the pol ORF. The nucleotide number
indicates the position at which the base has been changed. The concurrent change of amino acid residue in the core protein is indicated. (B)
Core particle-associated endogenous polymerase activity of wild type and 2310/2342 double mutant. The duplicated lanes of 2310/2299 in
panels B, C, and D are two independent isolates of mutant 2310/2299. (C) Northern blot analysis of the steady-state level of HBV-specific
transcripts in HepG2 cells transiently transfected with double mutants. (D) Southern blot analysis of intracellular and extracellular
HBV-specific DNAs from HepG2 cells transiently transfected with 2310/2342 double mutant. WT, Wild-type HBV; RC, relaxed circle; SS,
single stranded.
(RNA) blot analysis did not reveal any differences among
wild-type and any mutant HBV (data not shown). Taken
together, these data strongly suggest that fs does not occur
either downstream or upstream from the first ATG position
of pol within the c-pol overlap. Nevertheless, it is still
possible that fs occurs in the vicinity of positions 2306 to
2310. Another similar possibility is that the fs signal neces-
sary for the fs event (12) is located near this position. A
missense mutation at the first ATG may therefore have
abolished the fs signal.
One prominent band near the 4.3-kb position of the
relaxed circle ofHBV can also be detected in other mutants,
including mutant 2310 (Fig. 2B). This band does not appear
to represent a bona fide replicative intermediate, since
neither a positive pol assay result (Fig. 2C) nor the presence
of a characteristic single-stranded replicative intermediate
(Fig. 2B) has ever been observed in mutant 2310, 2471, or
305. In fact, when less donor DNA was used, this pseudosig-
nal disappeared (e.g., see Fig. 3).
Creation of internal novel ATG codons. To better under-
stand translational initiation of the pol gene, we created
novel ATG codons either 3 amino acids upstream (position
2299) or 11 amino acids downstream (position 2342) from the
mutated ATG codon in mutant 2310 (Fig. 3A). These double
mutants were analyzed in a manner similar to that described
previously (Fig. 3B and D). Both pol enzymatic assay and
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FIG. 4. Restoration of polymerase activity of mutant 2310 by
creation of an upstream ATG codon at nt 2299 after cotransfection
with pol-defective mutant such as 305, 2471, or 2310. Controls to
test for recombination were always included by cotransfecting two
different pol-defective mutants (e.g., 305 and 2310). RC, Relaxed
circle; SS, single stranded; WT, wild-type HBV.
Southern blot analysis clearly indicated that the missense
mutant 2310 can be rescued by providing a novel down-
stream ATG codon at nt 2342 (Fig. 3B and D). In order to be
certain that the difference between these mutants indeed
reflects a difference in translational control rather than in
transcriptional control or mRNA stability, we examined the
steady-state level of the 3.5-kb pol-specific mRNA in these
mutants by Northern blot analysis (Fig. 3C). Our results
indicate that these mutants do not differ from each other
regarding levels of all species of HBV-specific mRNAs. One
explanation for the failure to rescue the pol activity in double
mutant 2310/2299 is a concurrent structural alteration of the
core protein (from Arg to Gly at position 2299). Although the
core gene product of mutant 2310/2299 is detectable by
immunoprecipitation with anti-core antibody (data not
shown), it is possible that this mutated core protein is no
longer functional. In an attempt to complement the potential
defect of the core protein in double mutant 2310/2299 with a
functional core protein from mutant 2310, we cotransfected
this double mutant 2310/2299 with single mutant 2310. Nei-
ther single mutant 2310 nor double mutant 2310/2299 alone
was sufficient to produce detectable pol activity (Fig. 4).
When cotransfected with both mutant 2310 and double
mutant 2310/2299, cells showed wild-type levels of pol
activity. Similar results (Fig. 4) were obtained when DNA
replicative intermediates were assayed by Southern blot
analysis (data not shown). The possibility of rescue by DNA
recombination between a core-producing plasmid (mutant
2310) and a pol-producing plasmid (mutant 2310/2299) can be
excluded since in a control experiment, pol-truncated mu-
tant 305 did not rescue mutant 2310. This result proves not
only that rescue of mutant 2310 with an upstream ATG
codon is possible, but also that the core and pol proteins of
HBV can be synthesized separately.
DISCUSSION
Potential mechanisms of HBV pol gene expression. The
genetic data presented in this paper argue convincingly
against ribosomal fs or non-ATG initiation as a mechanism
of pol gene expression in HBV. Furthermore, they strongly
support the conclusion that the first ATG in the pol ORF is
essential for translational initiation. Several different mech-
anisms can explain this observation (Fig. 5). First, transla-
tion may occur by direct internal initiation, as recently
described for the picornavirus system (13, 29). A major
difference between picornavirus and 3.5-kb HBV-specific
mRNAs is that the former are naturally uncapped, while the
latter are believed to be capped (19, 20). The likely presence
of a capped structure at the 5' end of the 3.5-kb mRNA of
HBV does not argue against the possibility of direct internal
initiation, since it has been shown that methylated capped
poliovirus mRNA can be translated in vitro at an efficiency
FIG. 5. Potential strategies of HBV pol gene expression. See text for references.
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equal to that of the uncapped counterpart in a cap-indepen-
dent fashion (28). As described in the legend to Fig. 2, the
diminished pol activity of mutant 2306 cannot be explained
by the concurrent structural alteration of the core gene
product. If pol expression indeed involves direct internal
initiation, diminished activity of pol in mutant 2306 (from CC
AAATG to CTAAATG) can be explained by a perturbation
of unknown signals for direct internal initiation. Second, the
pol protein may be encoded by an as yet unidentified mRNA
species which exposes the ATG at nt 2310 as the 5'-most
proximal initiation codon. The scanning 40S ribosome sub-
unit would thus commence initiation at nt 2310 when it
encountered this first ATG of pol. It should be noted that this
hypothetical transcript has never been identified by primer
extension-nuclease Si mapping (3, 6, 24, 42). Third, it has
previously been proposed that ribosomes, after reaching the
stop codon, may be able to scan backwards and reinitiate at
the once-bypassed, upstream ATG codon (26, 27, 40). We
consider this a less likely possibility because the distance
between the end of the core gene (nt 2451) and the first ATG
of pol (nt 2310) is approximately 140 nt. This distance
appears to be too long for this type of reinitiation to take
place (26, 27). Another possibility, such as leaky scanning
(16, 17), is unlikely because within the 3.5-kb mRNA, there
are four or five ATG codons 5' upstream from the first ATG
of pol at nt 2310 in HBV subtype ayw. Moreover, some of
these upstream ATG codons are in optimal sequence context
for translational initiation, while the authentic ATG codon of
pol at nt 2310 and the created ATG codons at nt 2299 or 2342
are in poor sequence context, with a cytosine rather than a
purine at the -3 position (17). Neither RNA editing (36) nor
non-ATG initiation (9, 25, 31) appears to be consistent with
the data presented in Fig. 2, 3, and 4.
Although our studies of HBV pol gene translation are not
consistent with a previous report of detection of c-pol fusion
proteins in certain human hepatoma tissue (43), it should be
noted that human hepatoma tissues often contain integrated
and rearranged HBV DNA (34). Therefore, one likely inter-
pretation of this discrepancy is that the reported c-pol fusion
protein is actually produced from the rearranged HBV DNA
rather than synthesized as a natural product during the
normal life cycle of wild-type HBV.
Our observation of genetic complementation between
core-defective and pol-defective HBV plasmids argues
against c-pol fusion (Fig. 4) and substantiates an earlier
report on the duck HBV system (4, 33). As discussed in the
legend to Fig. 2, by itself the missense mutation of the first
ATG of pol at nt 2310 does not provide conclusive evidence
against fs occurring downstream from this position, since the
potential perturbation of a +1 fs signal cannot be excluded.
Our report here of the successful rescue of the missense
mutant 2310 by creation of an internal ATG constitutes
strong support for either direct internal initiation or the
existence of a novel species of mRNA responsible for pol
translation which may have escaped detection.
Packaging strategy of pol gene product. Of potential bio-
logical significance are the formation of a gag-pol fusion
protein in retroviruses and its ability to target and compart-
mentalize the pol gene product in the core particles during
packaging. Another aspect of potential significance is the
stoichiometric regulation of the gag and gag-pol products in
a proper ratio (for a review, see reference 8). However, the
biosyntheses of the nucleocapsid and the reverse tran-
scriptase appear to be separable in HBV (Fig. 3 and 4). This
is also the case in the closely related duck HBV (4, 33) and
even in cauliflower mosaic virus (30), another retroelement
in plants. The stoichiometric regulation of capsid and pol
gene products and the packaging strategy of pol during
morphogenesis of these viruses promise to be rewarding
areas of investigation in the future.
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